Clinical Trial Update: Levosimendan in Acute Heart Failure Following Acute Myocardial Infarction. [Phase 4]

View source ↗

Summary

Phase 4 clinical trial updates levosimendan for acute heart failure following acute myocardial infarction; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiogenic Shock
• Heart Failure
• Myocardial Infarction

Drugs mentioned

• Levosimendan (levosimendan)

Snippet

Sponsor: Oslo University Hospital | Conditions: Myocardial Infarction, Heart Failure | Phase 4 | Status: COMPLETED